Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea pigs

References

• Newmark J. Nerve agents. Neurologist 2007; 13:20–32.
   PubMed Web of Science ®Google Scholar
• Wetherell J, Price M, Mumford H. A novel approach for medical countermeasures to nerve agent poisoning in the guinea-pig. Neurotoxicology 2006; 27:485–491.
   PubMed Web of Science ®Google Scholar
• Masson P, Lockridge O. Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior. Arch Biochem Biophys 2010; 494:107–120.
   PubMed Web of Science ®Google Scholar
• Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 2007; 233:31–39.
   PubMed Web of Science ®Google Scholar
• Bjarnason S, Mikler J, Hill I, Tenn C, Garrett M, Caddy N, Sawyer TW. Comparison of selected skin decontaminant products and regimens against VX in domestic swine. Hum Exp Toxicol 2008; 27:253–261.
   PubMed Web of Science ®Google Scholar
• Duncan EJS, Brown A, Lundy P, Sawyer TW, Hamilton M, Hill I, Conley JD. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J Appl Toxicol 2002; 22:141–148.
   PubMed Web of Science ®Google Scholar
• Hamilton MG, Hill I, Conley J, Sawyer TW, Caneva DC, Lundy PM. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil Med 2004; 169:856–862.
   PubMed Web of Science ®Google Scholar
• Dalton CH, Hattersley IJ, Rutter SJ, Chilcott RP. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. Toxicol in Vitro 2006; 20:1532–1526.
   PubMed Web of Science ®Google Scholar
• Mumford H, Price ME, Wetherell JR. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig. J Appl Toxicol 2008; 28:694–702.
   PubMed Web of Science ®Google Scholar
• Vale JA, Rice P, Marrs TC. Managing civilian casualties affected by nerve agents. In: Marrs TC, Maynard RL, Sidell FR, eds. Chemical Warfare Agents: Toxicology and Treatment. Chichester: John Wiley & Sons, Ltd; 2007:249–260.
   Google Scholar
• Mumford H, Price ME, Cerasoli DM, Teschner W, Ehrlich H, Schwarz HP. Efficacy and physiological effects of human butyrycholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig. Chem Biol Interact 2010; 187:304–308.
   PubMed Web of Science ®Google Scholar
• Kolarich D, Weber A, Pabst M, Stadlmann J, Teschner W, Ehrlich H. Glycoproteornic characterization of butyrylcholinesterase from human plasma. Proteomics 2008; 8:254–263.
   PubMed Web of Science ®Google Scholar
• Weber A, Butterweck H, Mais-Paul U, Teschner W, Lei L, Muchitsch EM. Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical use. Vox Sang 2011; 100:285–297.
   PubMed Web of Science ®Google Scholar
• Wetherell JR. Continuous administration of low-dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J Pharm Pharmacol 1994; 46:1023–1028.
   PubMed Web of Science ®Google Scholar
• Wetherell J, Hall T, Passingham S. Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig. Neurotoxicology 2002; 23:341–349.
   PubMed Web of Science ®Google Scholar
• Wetherell J, Price M, Mumford H, Armstrong S, Scott L. Development of next generation medical countermeasures to nerve agent poisoning. Toxicology 2007; 233:120–127.
   PubMed Web of Science ®Google Scholar
• Lenz DE, Maxwell DM, Koplovitz I, Clark CR, Capacio BR, Cerasoli DM. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem Biol Interact 2005; 157:205–210.
   PubMed Web of Science ®Google Scholar
• Tenn CC, Mikler JR, Hill I, Weatherby K, Garrett M, Caddy N. Recombinant human butyrylcholinesterase as a therapeutic agent to counteract the effects of VX toxicity in domestic swine. J Med Chem Def 2008; 6.
   Google Scholar
• Lenz DE, Clarkson ED, Schultz SM, Cerasoli DM. Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX. Chem Biol Interact 2010; 187:249–252.
   PubMed Web of Science ®Google Scholar
• Sidell FR. A history of human studies with nerve agents by the UK and USA. In: Marrs TC, Maynard RL, Sidell FR, eds. Chemical Warfare Agents: Toxicology and Treatment. 2nd ed. Chichester: John Wiley & Sons, Ltd; 2007:223–239.
   Google Scholar
• van der Schans MJ, Lander BJ, van der Wiel H, Langenberg JP, Benschop HP. Toxicokinetics of the nerve agent (+/−)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol Appl Pharmacol 2003; 191:48–62.
   PubMed Web of Science ®Google Scholar
• Dorandeu F, Foquin A, Briot R, Delacour C, Denis J, Alonso A. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX. Toxicology 2008; 248:151–157.
   PubMed Web of Science ®Google Scholar
• Joosen MJA, van der Schans MJ, van Helden HPM. Percutaneous exposure to VX: clinical signs, effects on brain acetylcholine levels and EEG. Neurochem Res 2008; 33:308–317.
   PubMed Web of Science ®Google Scholar
• Shih TM, McDonough JH. Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication. Arch Toxicol 2000; 74:165–172.
   PubMed Web of Science ®Google Scholar
• Sun W, Doctor BP, Saxena A. Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs. Chem Biol Interact 2005; 157:428–429.
   PubMed Web of Science ®Google Scholar
• Sun W, Doctor BP, Lenz DE, Saxena A. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys. Chem Biol Interact 2008; 175:428–430.
   PubMed Web of Science ®Google Scholar
• Katos AM, Conti ML, Moran TS, Gordon RK, Doctor BP, Sciuto AM. Abdominal bloating and irritable bowel syndrome like symptoms following microinstillation inhalation exposure to chemical warfare nerve agent VX in guinea pigs. Toxicol Ind Health 2007; 23:231–240.
   PubMed Web of Science ®Google Scholar
• Che MM, Conti M, Chanda S, Boylan M, Sabnekar P, Rezk P. Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs. Toxicol Appl Pharmacol 2009; 239:251–257.
   PubMed Web of Science ®Google Scholar
• Worek F, Kirchner T, Szinicz L. Effect of atropine and bispyridinium oximes on respiratory and circulatory function in guinea-pigs poisoned by sarin. Toxicology 1995; 95:123–133.
   PubMed Web of Science ®Google Scholar
• Zhuang J, Xu F, Campen MJ, Zhang C, Pena-Philippides JC, Sopori ML. Inhalation of the nerve gas sarin impairs ventilatory responses to hypercapnia and hypoxia in rats. Toxicol Appl Pharmacol 2008; 232:440–447.
   PubMed Web of Science ®Google Scholar
• Eddleston M, Mohamed F, Davies JOJ, Eyer P, Worek F, Sheriff MHR, Buckley NA. Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM: An Int J Med 2006; 99:513–522.
   PubMed Web of Science ®Google Scholar